A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

Dravet Syndrome

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים

UCSF Benioff Children's Hospitals, San Francisco, California, United States
Contact: Study coordinator (Adam Numis, MD) · Adam.numis@ucsf.edu
Contact: Principal Investigator (Adam Numis)
Colorado Children's Hospital, Aurora, Colorado, United States
Contact: Study coordinator (Kallie Dock) · Kallie.dock@childrenscolorado.org · 720-777-5322
Nicklaus Children's Hospital, Miami, Florida, United States
Contact: Study coordinator (Matt Lallas) · Matt.Lallas@nicklaushealth.org · 305-662-8330
Contact: Study coordinator (Dainelys Pena Rodriguez) · Dainelys.PenaRodriguez@nicklaushealth.org · 786-624-3547
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
Contact: Study coordinator (Enrique Rojas) · erojas@luriechildrens.org · 312-227-2532
Contact: Principal Investigator (Linda Laux)
Boston Children's Hospital, Boston, Massachusetts, United States
Contact: Study coordinator (Melissa DiBacco) · Melissa.DiBacco@childrens.harvard.edu · 617-919-4617
Mott Children's Hospital, Ann Arbor, Michigan, United States
Contact: Study coordinator (Stephanie Rau) · shatchew@med.umich.edu · 734-232-8474
Mayo Clinic, Rochester, Minnesota, United States
Contact: Study coordinator (Bridget Neja) · neja.bridget@mayo.edu · 507-266-9150
Duke Children's Hospital & Health Center, Durham, North Carolina, United States
Contact: Study coordinator (Makenzi Buchanan) · Makenzi.hayes@duke.edu · 919-613-1232
Nationwide Children's Hospital, Columbus, Ohio, United States
Contact: Study coordinator (Kaitlyn Brown) · Kaitlyn.brown2@nationwidechildrens.org · 614-722-2286
Oregon Health and Science University (OSHU), Portland, Oregon, United States
Contact: Study coordinator (Emily Stein) · steine@ohsu.edu
Cook Children's Medical Center, Fort Worth, Texas, United States
Contact: Study coordinator (Dianna Grado, RN, CCRC) · Dianna.Grado@cookchildrens.org · (682) 885-2844
Contact: Principal Investigator (Scott Perry)
The Royal Children's Hospital, Melbourne, Australia
Contact: Study coordinator (Prof. Ingrid Scheffer)
Contact: Study coordinator (Dr. Katherine Howell)
Queen Elizabeth Hospital, Glasgow, United Kingdom
Contact: Study coordinator (Patricia Clark) · Patricia.Clark2@ggc.scot.nhs.uk · 0141 232 7600
Great Ormond Street Hospital, London, United Kingdom
Contact: Study coordinator (Helen Cross, MD) · helen.cross10@nhs.net

מובילי המחקר

Salvador Rico, M.D., Ph.D
Study Director
Encoded Therapeutics

צפייה במקור ב־ClinicalTrials.gov

ניסויים דומים

ניסויים נוספים שמגייסים כעת ועשויים להיות רלוונטיים לפי מצב רפואי, טיפול, שלב או מיקום

ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome

Dravet Syndrome

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1, PHASE2

Ann Arbor, United States · Rochester, United States

BMB-101 in Absence Epilepsy and DEE

Absence Epilepsy · Jeavons Syndrome · Dravet Syndrome

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE2

Randwick, Australia · Herston, Australia

A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevunersen in Patients With Dravet Syndrome

Dravet Syndrome

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

Phoenix, United States · Little Rock, United States

A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

Dravet Syndrome

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

Birmingham, United States · Little Rock, United States